Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Anti-Inflammatory Effects of Budesonide in Human Fetal Lung


ABSTRACT: Rationale. Lung inflammation in premature infants contributes to development of bronchopulmonary dysplasia (BPD), a chronic lung disease with long-term sequelae. Pilot studies administering budesonide suspended in surfactant have found reduced BPD without apparent adverse effects as occur with systemic dexamethasone therapy. Objectives. To determine effects of budesonide on differential genes expression in human fetal lung Methods. We prepared RNA from 3 samples of human fetal lung at 23 weeks gestation before (preculture, PC) and after 4 days culture as explants with (Bud) or without (Way) budesonide (30 nM) and performed RNAseq on the 9 samples.

ORGANISM(S): Homo sapiens

SUBMITTER: Philip Ballard 

PROVIDER: E-GEOD-83888 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Antiinflammatory Effects of Budesonide in Human Fetal Lung.

Barrette Anne Marie AM   Roberts Jessica K JK   Chapin Cheryl C   Egan Edmund A EA   Segal Mark R MR   Oses-Prieto Juan A JA   Chand Shreya S   Burlingame Alma L AL   Ballard Philip L PL  

American journal of respiratory cell and molecular biology 20161101 5


Lung inflammation in premature infants contributes to the development of bronchopulmonary dysplasia (BPD), a chronic lung disease with long-term sequelae. Pilot studies administering budesonide suspended in surfactant have found reduced BPD without the apparent adverse effects that occur with systemic dexamethasone therapy. Our objective was to determine budesonide potency, stability, and antiinflammatory effects in human fetal lung. We cultured explants of second-trimester fetal lung with budes  ...[more]

Similar Datasets

2016-06-30 | GSE83888 | GEO
2013-04-23 | GSE39029 | GEO
2013-04-23 | E-GEOD-39029 | biostudies-arrayexpress
2016-01-15 | E-GEOD-70208 | biostudies-arrayexpress
2024-02-21 | GSE219156 | GEO
2023-07-04 | GSE220843 | GEO
2018-11-15 | GSE106910 | GEO
2022-10-25 | GSE211356 | GEO
2022-05-05 | GSE188944 | GEO
2023-03-15 | MSV000091493 | MassIVE